By Dr. Ray Brig January 10, 2016

Michael E. Williams, MD, ScM, the Cancer.Net Associate Editor for Lymphoma, recently attended the American Society of Hematology Annual Meeting. During the meeting, doctors discussed new treatment approaches for lymphomas and leukemias. Dr. Williams reports on the main highlights in this podcast:
“Mike is one of my mentors years past. One of the great lymphoma clinicians, educators, and researchers. It was my privileged to be trained by one of the best”-Raymond Brig MD

Research comparing two targeted therapies, ibrutinib (Imbruvica) and temsirolimus (Torisel), for relapsed mantle cell lymphoma [3:45]
Early studies that showed impressive results on various drugs for chronic lymphocytic leukemia and non-Hodgkin lymphoma [6:50]
Listen to Dr. Williams